Page 86 - 北京京煤集团总医院第十一届·2023学术年会论文集

北京京煤集团总医院 第十一届·2023 学术年会论文集

1,” Arterioscler.Thromb.Vasc.Biol.,vol.18,no.1, pp.1–6, Jan.1998, doi: 10.1161/01.atv.18. 1.1
[9] A. D. Weisberg et al., “Pharmacological inhibition and genetic deficiency of plasminogen

activator inhibitor-1 attenuates angiotensin II/salt-induced aortic remodeling,” Arterioscler.
Thromb.Vasc.Biol.,vol.25,no.2,pp.365–371,Feb.2005,doi:10.1161/01.ATV.0000152356.85791. 52.
[10] B. Khwannimit, R. Bhurayanontachai, and V. Vattanavanit, “Comparison of the performance
of SOFA, qSOFA and SIRS for predicting mortality and organ failure among sepsis patients

admitted to the intensive care unit in a middle-income country,” J. Crit. Care, vol. 44, pp. 156–160,
Apr. 2018, doi: 10.1016/j.jcrc.2017.10.023.
[11] W. Tang, M.-L. Zha, W.-Q. Zhang, S.-Q. Hu, and H.-L. Chen, “APACHE scoring system and
pressure injury risk for intensive care patients: A systematic review and meta-analysis,” Wound

Repair Regen. Off. Publ. Wound Heal. Soc. Eur. Tissue Repair Soc., vol. 30, no. 4, pp. 498–508, Jul.
2022, doi: 10.1111/wrr.13021.
[12] S. Madoiwa et al., “Plasminogen activator inhibitor 1 promotes a poor prognosis in sepsis-
induced disseminated intravascular coagulation,” Int. J. Hematol., vol. 84, no. 5, pp. 398–405, Dec.

2006, doi: 10.1532/IJH97.05190.

- 82 -